ATOSSA THERAPEUTICS, INC. Quarterly Return On Equity in % from Q2 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Atossa Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2013 to Q3 2024.
  • Atossa Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -32.6 %, a 18.5% decline year-over-year.
  • Atossa Therapeutics, Inc. annual Return On Equity for 2023 was -29.6 %, a 39% decline from 2022.
  • Atossa Therapeutics, Inc. annual Return On Equity for 2022 was -21.3 %, a 45.3% decline from 2021.
  • Atossa Therapeutics, Inc. annual Return On Equity for 2021 was -14.6 %, a 88.4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -32.6 -5.09 -18.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -29.2 -1.69 -6.15% Apr 1, 2024 Jun 30, 2024
Q1 2024 -31.3 -7.81 -33.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -29.6 -8.29 -39% Oct 1, 2023 Dec 31, 2023
Q3 2023 -27.5 -9.04 -49% Jul 1, 2023 Sep 30, 2023
Q2 2023 -27.5 -11.7 -74.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -23.5 -7.81 -49.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -21.3 -6.63 -45.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -18.4 +2.14 +10.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -15.8 +11.1 +41.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -15.7 +24.2 +60.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -14.6 +112 +88.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -20.6 +102 +83.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -26.9 +80.7 +75% Apr 1, 2021 Jun 30, 2021
Q1 2021 -39.8 +74 +65% Jan 1, 2021 Mar 31, 2021
Q4 2020 -127 -20.9 -19.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -123 -12.9 -11.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -108 +11 +9.28% Apr 1, 2020 Jun 30, 2020
Q1 2020 -114 -10.1 -9.69% Jan 1, 2020 Mar 31, 2020
Q4 2019 -106 +13.7 +11.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -110 +14.9 +11.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -119 +25.4 +17.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -104 +85.1 +45.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -119 +115 +49.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -125 +222 +64% Jul 1, 2018 Sep 30, 2018
Q2 2018 -144 +51.1 +26.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -189 -4.3 -2.33% Jan 1, 2018 Mar 31, 2018
Q4 2017 -235 -61.5 -35.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -346 -117 -50.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -195 +85.8 +30.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -185 +14.1 +7.11% Jan 1, 2017 Mar 31, 2017
Q4 2016 -173 +0.74 +0.43% Oct 1, 2016 Dec 31, 2016
Q3 2016 -230 -71.3 -45% Jul 1, 2016 Sep 30, 2016
Q2 2016 -281 -152 -118% Apr 1, 2016 Jun 30, 2016
Q1 2016 -199 -81.7 -69.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -174 -82.9 -90.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -158 -87.4 -123% Jul 1, 2015 Sep 30, 2015
Q2 2015 -129 -52.2 -67.9% Apr 1, 2015 Jun 30, 2015
Q1 2015 -117 -30 -34.4% Jan 1, 2015 Mar 31, 2015
Q4 2014 -91.2 +24.2 +20.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 -71 +50.8 +41.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -76.9 +46.9 +37.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -87 Jan 1, 2014 Mar 31, 2014
Q4 2013 -115 Oct 1, 2013 Dec 31, 2013
Q3 2013 -122 Jul 1, 2013 Sep 30, 2013
Q2 2013 -124 Apr 1, 2013 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.